Orthovisc FDA Approval History
FDA Approved: Yes (First approved February 4, 2004)
Brand name: Orthovisc
Generic name: sodium hyaluronate
Dosage form: Injection
Company: Anika Therapeutics, Inc.
Treatment for: Osteoarthritis
Orthovisc is a highly purified, high molecular weight form of hyaluronic acid used for treating pain in patients suffering from osteoarthritis (OA) of the knee who have failed to respond adequately to conservative non-pharmacologic therapy and to simple analgesics.
Development timeline for Orthovisc
| Date | Article |
|---|---|
| Feb 5, 2004 | Approval Orthovisc Anika Therapeutics, Inc. - Treatment for Osteoarthritis of the Knee |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.